Skip to main content

Main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers

Secondary navigation

  • Value added services
  • CSR
  • About us

SearchSearch results for: “域名价值评估HTTPS证书,域名价值评估促销,域名价格评估英文单词域名,域名评估网域名投资组合,域名估价工具使用教程文档,等欢迎访问估价程序 V.25.11.01官方网站:www.gu.cx”

268 results

ECJ in Unilever: commercial policy by dominant undertakings on thin ice

Unilever shows the need to assess evidence on lack of anti-competitive effects in abuse cases and how liability can extend across different levels of the supply chain. Dominant undertakings had better think twice when imposing policy on distributors.

Sense and sensibility in sustainability collaborations

The ACM’s push for companies to come forward for an antitrust blessing of their sustainability solutions is paying off. The ACM has again given informal guidance to companies wishing to make sustainability agreements.

Belgian Competition Authority opens first hybrid cartel proceedings

In the first hybrid cartel proceedings by the Belgian Competition Authority, the Prosecutor recently submitted a draft decision to condemn and impose a fine on pharmaceutical wholesaler CERP SA for allegedly participating in anticompetitive practices.

Spooked no more: antitrust safe harbour for solo self-employed persons

The Commission’s guidelines on collective agreements clarify the manoeuvre room solo self-employed persons have under the competition rules to collectively boost their working conditions. A Directive on platform work working conditions is on the way.

FSR zorgt voor nieuwe uitdagingen bij transacties en aanbestedingen

Op 12 januari van dit jaar trad de Foreign Subsidies Regulation (FSR) in werking, die per 12 oktober een meldplicht bij de Europese Commissie voor bepaalde transacties en aanbestedingen introduceert.

Dutch national security screening regime enters into force

The Dutch national security screening regime (Wet veiligheidstoets investeringen, fusies en overnames or Wet Vifo) enters into force today, 1 June.

Levelling the playing field in 2023: new tools and hurdles

While 2022 revolved around new and improved regulatory tools, the focus in 2023 will be on putting these tools to use. More merger-related obligations, digital sector scrutiny and clarity on competition-law and consumer-law aspects is imminent.

The long and (un)winding road of ‘killer acquisition’ Illumina/Grail

Crystal ball gazing into prospective innovation rat races when assessing vertical mergers may soon be all in a day’s work for the European Commission. Innovation was a recurring theme in the Commission’s handling of the Illumina/Grail deal.

If you have nothing nice to say…Teva fined heavily for abusive conduct

Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and ‘divisional gaming’ to delay market entry and hinder the uptake of a competing drug.

The ECJ’s ruling in Servier: Never Settle For Less

Patent settlement agreements between originator pharmaceutical companies and generics manufacturers are a risky business. Originator medicine company Servier and five generic companies rolled the dice and the ECJ largely confirmed their antitrust fines.

Commission steers market definition to the 21st century

Companies have a new and improved tool for the competitive assessment of their conduct and intended acquisitions. The European Commission has updated its guidance on how to define relevant markets for the purpose of EU competition law enforcement.

Stibbe advises Seven2

Stibbe advised Seven2 on the acquisition of a majority stake in Zwart Techniek.

Commission publishes PSD3 and PSR Proposal; a tightening of the regulation of payment services providers in the EU

On June 28, 2023, the European Commission published a set of new legislative proposals, including PSD3, aimed at ushering in the digital era for payments and the broader financial sector, with a particular focus on consumers.

Belgian Competition Authority confirms jurisdiction for M&A transactions in hospital sector

On 14 July 2023, the Belgian Competition Authority confirmed its jurisdiction to review M&A transactions between hospitals, regardless of whether these hospitals belong to the same hospital network.

The era of FDI screenings kicks off in Belgium

The Belgian screening mechanism for FDIs will enter into force on 1 July 2023. The mechanism is designed to safeguard Belgium's critical infrastructure and to protect sectors crucial to Belgium's public order, national security and strategic interests.

Upward referral of killer acquisitions: enlightened or one-stop shop flop?

Companies involved in M&A deals falling below the EU and national notification thresholds need to think twice about their deal’s potential impact on competition from now on.

Second time lucky: Intel’s EUR 1.06 billion loyalty rebate fine quashed

Intel’s second round at the General Court was significantly more successful than its first. In the first round, the General Court had failed to analyse whether the loyalty rebates at issue were capable of restricting competition. In the second round, afte

ECJ: private enforcement in aviation sector also a national court's game

Recently, the ECJ ruled that national courts dealing with private enforcement cases are competent to apply EU competition law to historical behaviour in the aviation sector.

Pagination

  • Previous page
  • Page 11
  • Current page 12
  • Page 13
  • Page 14
  • Next page
Reset filters
Date
Content type
  • Article (247)
  • Event (1)
  • Inside Stibbe (6)
  • Matter (11)
  • Podcast (3)
Expertise
  • (-) EU and Competition Law (268)
  • Audit Firms and Accountancy (20)
  • Banking and Finance (136)
  • Capital Markets (77)
  • Compliance, Sanctions and Risk (59)
  • Corporate and M&A (316)
  • Corporate Investigations (8)
  • Criminal Law and Enforcement (58)
  • Employment, Benefits and Pensions (125)
  • Energy, Industry and Climate (129)
  • Environment and Planning (602)
  • ESG & Sustainability (183)
  • Financial Regulation (91)
  • Healthcare and Life Sciences (16)
  • Infrastructure and Mobility (40)
  • Insurance (6)
  • Intellectual Property (20)
  • Investment Funds (41)
  • Litigation and Arbitration (147)
  • Mass Litigation (31)
  • Privacy and Data Protection (90)
  • Private Equity (33)
  • Procurement Law (23)
  • Public Law (743)
  • Real Estate (130)
  • Restructuring and Insolvency (29)
  • Tax (130)
  • Tech (78)
  • Technology, Media and Telecommunications (118)
  • Unfair Competition and Consumer Protection (69)
Jurisdiction
  • BE Law (24)
  • EU Law (210)
  • LU Law (9)
  • NL Law (192)
Language
  • Dutch (32)
  • English (235)
  • French (1)

Footer main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers
© 2026 Stibbe

Footer navigation

  • Contact
  • Disclaimer
  • General Conditions
  • Register of legal practice areas
  • Privacy and Cookie Policy
  • Important Information